However, if your physician has ordered a test to be performed in one of our clinical laboratories, please choose the location that best fits your needs from the options below. (2015) Different temporal effects of Ebola virus VP35 and VP24 on global gene expression in human dendritic cells. M. Meyer, E. Huang, O. Yuzhakov, P. Ramanathan, G. Ciaramella, and A. Bukreyev (2018) Modified mRNA-based vaccines elicit robust immune responses and protect guinea pigs from Ebola virus disease. J. Virol. Alexander Bukreyev's Lab. The article was chosen for American Society of Microbiology and UTMB press releases on 09/26/2017. M. Meyer, D. C. Malherbe and A. Bukreyev (2019). P. Gilchuk, N. Kuzmina, P. A. Ilinykh, K. Huang, B. M. Gunn, A. Bryan, E. Davidson, B. J. Doranz, H. L. Turner, M. L. Fusco, M. S. Bramble, N. A. Hoff, E. Binshtein, N. Kose, A. I. Flyak. J. Infect. Review article. N. A. Kuzmina, P. Younan, P. Gilchuk, R. I. Santos, A. I. Flyak, P. A. Ilinykh, K. Huang,   N. M. Lubaki, P. Ramanathan, J. E. Crowe, Jr.and A. Bukreyev (2018). Individuals interested in joining the lab as a Research Associate, a Postdoctoral Fellow or a Research Scientist should send a brief email and CV or resume directly to Dr. Bukreyev. R. F. Russell, J. U. McDonald, M. Ivanova, Z. Zhong, A. Bukreyev, J. S. Tregoning. The article was chosen for PNAS press release on 12/09/02. P. A. Ilinykh, B. Tigabu, A. Ivanov, T. Ammosova,  Y. Obukhov, T. Garron, N. Kumari, D. Kovalskyy, M. O. Platonov, V. S. Naumchik,A. Our research includes experiments in a BSL-2 labs and in BSL-4 labs of the Galveston National Laboratory. A. Bornholdt, J. C. Slaughter, G. Sapparapu, T. G. Ksiazek, A. Cell Reports 24: 1802-1815. J. Infect. Invest. Irma Cisneros, PhD Director, Pathology Imaging Core Lab Email: ircisnero@utmb.edu Phone: (409) 772-3938. Vodzak, S. Li, A. Okoli, M. Ibeawuchi, Ohiaeri, G.K. Lewis, G. Alter, A. Bukreyev, E. Ollmann Saphire, T.W. 1994-1996. mBio 8(2) e00226-17. The secreted form of the G glycoprotein of respiratory syncytial virus helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects of Fc receptor-bearing leucocytes. Immunity. B. Our research includes the following specific topics: Pyatigorsk Pharmaceutical Institute, Pyatigorsk, Russia. Expert Review of Vaccines, 9 (1):5-8. Turner, T. Alkutkar, R. Flinko, C. Orlandi, R. Carnahan, R. Nargi, R.G. Science. degree in electrical and computer engineering and physics from the University of Florida, Gainesville, FL, USA, in 2013. Newcastle disease virus as a vaccine vector for humans. (2006). Our research is supported by grants from NIH and DoD. Barrett, PhD Professor, Departments of Pathology and Microbiology & Immunology John D. Stobo, MD Distinguished Chair in Vaccinology … Proc. J. Virol. Convener of the Filoviruses Workshop, 30th Annual Meeting of American Society for Virology, University of Minnesota, Minneapolis, Minnesota. A. Bukreyev, L. Yang, S. R. Zaki, W-J. Gunn, A.L. Ward, E. O. Saphire, A. Bukreyev*, and J. E. Crowe, Jr.* (2015) Mechanism of human antibody-mediated neutralization of Marburg virus. Review. J. Virol. P. Younan, P. Ramanathan, J. Graber, F. Gusovsky, and A. Bukreyev. Cell 160(5): 893-903. July 16, 2011. Ward. Antibody-mediated protective mechanisms induced by a trivalent parainfluenza-vectored ebolavirus vaccine. Acad. PLOS Pathogens 15(10):e1008068. P. Ilinykh, M. Lubaki, S. Widen, L. A. Renn, T. C. Theisen, N. R. Rabin, T. Wood, and A. Bukreyev (2015) Different temporal effects of Ebola virus VP35 and VP24 on global gene expression in human dendritic cells. H. Bisht, A. Roberts, L. Vogel, A. Bukreyev, P. Collins, B. Murphy, K. Subbarao, and B. Moss (2004). Dr. Alex Bukreyev at the University of Texas Medical Branch and the Galveston National Laboratory reports, “Our lab tested a panel of antibodies against a real SARS-CoV-2 in biocontainment. If you are experiencing a sudden or severe change in your health, or otherwise need an immediate response, call 911 or contact your provider's office by telephone. A. Bukreyev, I. M. Belyakov, J. A. Bukreyev, A. Marzi, F. Feldmann, L. Zhang, L. Yang, J. M. Ward, D. Dorward, R. J. Pickles, B. R. Murphy, H. Feldmann, and P. L. Collins (2009). PLOS Pathogens 21(12):e1006031. Convener of the Vaccine and Viral Vectors III Workshop, 28th Annual Meeting of American Society for Virology, University of British Columbia, Vancouver, Canada. Dis. Dis. J. Infect. Journal of Infectious Diseases 218 (Suppl. In: Advances in virus research, 54:423-451. Springer, ISBN 3-211-20671-X. Vaccine 29:17-25. P. Younan, M. Iampietro, A. Nishida, P. Ramanathan, R. I. Santos, M. Dutta, N. M. Lubaki, R. A. Koup, M. G. Katze, and A. Bukreyev. In 2017-2018, UTMB CLS graduates earned 100% ASCP Board of Certification one-year pass rate. Trends in Microbiology 27(1):8-16. (2017). *Co-corresponding author. Implementation of objective PASC-derived taxon demarcation criteria for official classification of Filoviruses. For additional information regarding laboratory access, training, experiments, please contact Dr. … 79:1113-1124. S. Munir, C. Luongo, C. Le Nouen, U. J. Buchholz, P. L. Collins, and A. Bukreyev (2008). Journal of Infectious Diseases 218(Suppl. (2017). UTMB’s relationship with China dates back to 2013, when the medical branch opened discussions with three labs that were under construction, including the facility in Wuhan. , N. Kuzmina, C. D. Murin, C. Bryan, E. Davidson, P. Gilchuk, C. P. Gulka, P. A. Ilinykh, X. Shen, P. Ramanathan, K. Huang, H. Turner, M. L. Fusco, R. Lampley, N. Kose, H. King. Multifunctional pan-ebolavirus antibodies recognize a site of broad vulnerability on the ebolavirus glycoprotein. N. M. Lubaki, P. Ilinykh, C. Pietzsch, B. Tigabu, A. N. Freiberg, R. A. Koup, and A. Bukreyev (2013). A. Kotelkin, I. M. Belyakov, L. Yang, J. Ilinykh, K. Huang, N. Kuzmina, P.X. Arch. Syst. (2018). Member of the Filoviridae Study Group of the International Committee on Taxonomy of Viruses, 2012-present. 90(8): 3890-901. The HPIV3-vectored intranasal vaccine against Ebola virus is immunogenic in HPIV3-immune animals. Our collaborators include Dr. James Crowe, Jr. (Vanderbilt University), Dr. Chris Basler (Mount Sinai), Dr. Sergei Nekhai (Howard University), Dr. Thomas Geisbert (UTMB), Dr. Siba Samal (University of Maryland), Dr. Scott Weaver (UTMB), Dr. Raul Andino (UCSF), and Dr. Werner Braun (UTMB). The article was chosen for UTMB press release on 05/02/13. (2017). The article was chosen for UTMB press release on 05/02/13. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses. The University of Texas Medical Branch at Galveston, Graduate Training in Experimental Pathology, Pathology Residency & Fellowship Program, Paul Brindley Distinguished Professorship, Pathology Microscope Imaging Core Laboratory, 2018 DMT Conference UTMB Faculty & Staff Registration, American Society for Virology, Full Member. The Master of Science degree in Clinical Laboratory Science (MSCLS) in the School of Health Professions is designed to prepare the clinical laboratory scientist for a career in research, teaching or management within clinical laboratory medicine. Ebolavirus chimerization for the development of a mouse model for screening of Bundibugyo-specific antibodies. Sci. Beer, R. Kurth, and A. Bukreyev (1999). Review. A. Bornholdt, J. C. Slaughter, G. Sapparapu, T. G. Ksiazek, A. mBio 8(5) e00845-17. J. M. DiNapoli, L. Yang, A. Suguitan Jr., S. Elankumaran, B. R. Murphy, S. K. Samal, P. L. Collins, and A. Bukreyev (2007). G. K. Amarasinghe, N. A. Ceballos, A. C. Banyard, C. F. Basler, S. Bavari, A. J. Bennett, K. R. Blasdell, T. Briese, A. Bukreyev, Y. Cai, et al. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection. Role of TMEM16F in the incorporation phosphatidylserine into budding ebolavirus virions. 80:10293-10306. P. Gilchuk, N. Kuzmina, P. A. Ilinykh, K. Huang, B. M. Gunn, A. Bryan, E. Davidson, B. J. Doranz, H. L. Turner, M. L. Fusco, M. S. Bramble, N. A. Hoff, E. Binshtein, N. Kose, A. I. Flyak,, R. Flinko, C. Orlandi, R. Carnahan, E. H. Parrish, A. M. Sevy, R. G. Bombardi, P. K. Singh, P. Mukadi, J. J. Muyembe-Tamfum, M. D. Ohi, E. Ollmann Saphire , G. K. Lewis, G. Alter, A. J. Virol. The article was chosen for Icahn School of Medicine at Mount Sinai press releases on 4/28/2016. M. Iampietro, R. I. Santos, N. M. Lubaki and A. Bukreyev (2018). G. Liu, P. Nash, B. Johnson, C. Pietzsch, M. Ilagan, A. Bukreyev, C. Basler, T. Bowlin, D. Moir, D. Leung, and G. Amarasinghe. Dis. M. Meyer, A. Yoshida, P. Ramanathan, E. Ollmann Saphire, P. Collins, J. E. Crowe Jr., S. Samal and A. Bukreyev (2018). (2018). Ana Kalichava (Aug 2016, UTMB), Democratic Republic of Georgia Charles (Sam) Umbaugh (2014, UTMB), Graduate Cell Biology and Neuroscience Devan Rostorfer (2013, UM), Undergraduate Lab … A. Bukreyev, B. R. Murphy, and P. L. Collins (2000). Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. 80:5854-5861. Antibody-mediated protective mechanisms induced by a trivalent parainfluenza-vectored ebolavirus vaccine. Natl. A. Rialdi, L. Campisi, N. Zhao, A. C. Lagda, C. Pietzsch, J. S. Ho, L. Martinez-Gil, R. Fenouil, X. Chen, M. Edwards, G. Metreveli, S. Jordan, Z. Peralta, C. Muniz-Fontela, N. Bouvier, M. Merad, J. Jin, M. Weirauch, S. Heinz, C. Benner, H. van Bakel, C. Basler, A. Garcia-Sastre, A. Bukreyev, and I. Marazzi. Comparative immunology of bats as a reservoir of filoviruses (in collaboration with Dr. Chris Basler). M. Meyer, T. Garron, N. M. Lubaki, C. E. Mire, K. A. Fenton, C. Klages, G. G. Olinger, T. W. Geisbert, P. L. Collins, and A. Bukreyev. Y. Bao, G. K. Amarasinghe, C. F. Basler, S. Bavari, A. Bukreyev, K. Chandran, O. Dolnik, J. M. Dye, H. Ebihara, P. Formenty, R. Hewson, G. P. Kobinger, E. M. Leroy, E. Muhlberger, S. V. Netesov, J. L. Patterson, J. T. Paweska, S. J. Smither, A. Takada, J. S. Towner, V. E. Volchkov, V. Wahl-Jensen, and J. H. Kuhn. (2016). Ebolavirus chimerization for the development of a mouse model for screening of Bundibugyo-specific antibodies. Cell Host & Microbe 23(1):101-109. Disabling of lymphocyte immune response by Ebola Virus.PLOS Pathogens 14(4):e1006932. E. Ollmann Saphire , G. K. Lewis, G. Alter, A. The article was chosen for J. Virol. The UTMB Department of Clinical Laboratory Sciences has the career path for you. (2017). M. Meyer, D. C. Malherbe and A. Bukreyev (2018). J. Infect. Disruption of phosphatidylserine synthesis or trafficking reduces infectivity of Ebola virus. J. Virol. Bombardi, M.E. B. July 14, 2009. Cell Reports 24: 1802-1815. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Development of therapeutic human monoclonal antibody treatments. B. R. West, A. Mol. Cross-reactive, neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains. PLOS Pathogens 13(5):e1006397. Effects of human respiratory syncytial virus, metapneumovirus, paramyxovirus type 3, and influenza A virus on the ability of human dendritic cells to activate autologous CD4 T cells. Dive into the research topics where Alexander Bukreyev is active. Immunity 49(2):363-374. (2016). 90(8): 3890-901. CDC Goes to Highest Alert Over Zika Outbreak | US News. To get insight into these scietific topics, we are using molecular tools, including reverse genetics (i.e. Successful topical respiratory tract immunization of primates against Ebola virus. Cross-reactive, neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nature Communications 10 (1):1788. A. I. Flyak, N. Kuzmina, C. D. Murin, C. Bryan, E. Davidson, P. Gilchuk, C. P. Gulka, P. A. Ilinykh, X. Shen, P. Ramanathan, K. Huang, H. Turner, M. L. Fusco, R. Lampley, N. Kose, H. King, G. Sapparapu, B. J. Doranz, T. G. Ksiazek, D. W. Wright, E. Ollmann Saphire, A. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication. The article was chosen for UTMB press releases on 05/24/2017. Interleukin 18 co-expression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. The article was chosen for UTMB and the Vanderbilt University press releases on 5/26/2015. What are the risks - hypothetical and observed - of recombination involving live vaccines and vaccine vectors based on nonsegmented negative strand RNA viruses? (2017). Characterization of antibody responses to filovirus infections in humans, in collaboration with Dr. James Crowe, Jr. (Vanderbilt University). J. Virol. 87(13):7471-7485. P. Younan, M. Iampietro, R. I. Santos, P. Ramanathan, V. L. Popov and A. Bukreyev (2018). Neutralizing antibodies from human survivors target a conserved site in the ebolavirus glycoprotein HR2/MPER regions. K. A. Dave, E. L. Norris, A. T. Ammosova, C. A. Pietzsch, Y. Saygideğer, A. Ilatovsky, X. Lin, A. Ivanov, N. Kumari, M. Jerebtsova, A. Kulkarni, M. Petukhov, A. Üren, A. Bukreyev* and Sergei Nekhai* (2018). Our Lab focuses on investigation of the mechanisms of the high pathogenicity of viruses Ebola, Marburg and Lassa and development of vaccines and antibody treatments against these viruses. Journal of Infectious Diseases 218 (Suppl. Welcome to the Department of Anesthesiology, UTMB Health, UTMB.edu Ward, A. W. Rimoin, A. Bukreyev*, and J. E. Crowe, Jr*. Topoisomerase II inhibitors induce DNA Damage dependent interferon responses circumventing Ebola virus immune evasion. In press. M. Meyer, A. Yoshida, P. Ramanathan, E. Ollmann Saphire, P. Collins, J. E. Crowe Jr., S. Samal and A. Bukreyev (2018). I. V. Kuzmin, T. M. Schwarz, P. A. Ilinykh, I. Jordan, T. G. Ksiazek, R. Sachidanandam, C. F. Basler, and A. Bukreyev (2017). Virology Journal 5:105. Archives of Virology 163(8):2283-2294. Can Ebola virus vaccines have universal correlates of protection? King, M. L. Fusco, A. I. Flyak, P. A. Ilinykh, K. Huang, B. Gunn, R. N. J. Harker, A. Godlee, J. L. Walhsten, D. C. P. Lee, L. Thorne, D. Sawant, J. S. Tregoning, R. Caspi, A. Bukreyev, P. L. Collins, and P. J. M. Openshaw (2010). B. Proc. Assymetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. (2014) A comprehensive proteomic view of responses of A549 cells to human respiratory syncytial virus infection. 5): S335-S345. Ebola virus (EBOV) in humans causes a severe illness with high mortality rates. 8(2) e00368-17. Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription Cellular and Molecular Life Sciences *Co-corresponding author. Neonatal antibody responses are attenuated by interferon gamma produced by CD8 and NK cells during RSV infection (2013). Trends in Microbiology 27(1):8-16. 8(2) e00368-17. The TLR4 antagonist Eritoran protects mice from lethal filovirus challenge. Cell. Geisbert, A.B. A. Rialdi, L. Campisi, N. Zhao, A. C. Lagda, C. Pietzsch, J. S. Ho, L. Martinez-Gil, R. Fenouil, X. Chen, M. Edwards, G. Metreveli, S. Jordan, Z. Peralta, C. Muniz-Fontela, N. Bouvier, M. Merad, J. Jin, M. Weirauch, S. Heinz, C. Benner, H. van Bakel, C. Basler, A. Garcia-Sastre, A. Bukreyev, and I. Marazzi. (2017). 217(2):451-455. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Together they form a unique fingerprint. A. Bukreyev, P. E. Rollin, M. Tate, L. Yang, S. R. Zaki, W.-J. L. Yang, A. Sanchez, P. E. Rollin, B. R. Murphy, P. L. Collins, and A. Bukreyev (2008). Bats seem to be natural reservoirs for coronaviruses and now, new research from the University of Texas Medical Branch (UTMB) at Galveston indicates the small mammals are also kind hosts to Ebola. J. Virol. 217(2):451-455. Acad. Baker W.S., Negi S.S, Braun. Chimeric respiratory paramyxovirus bearing Ebola glycoprotein as a sole envelope protein for prevention of Ebola virus infection. 92(21):e00426-18. Cell Reports 24: 1816-1829. 5): S627-S635. Innate immune response of bat and human cells to filoviruses: commonalities and distinctions. L. B. Department: Department of Pathology. Our research is supported by multiple sources, including R01 and multiple U19 grants from NIH, and grants from DTRA (DoD) and the Department of Homeland Security. Alexander BUKREYEV, Professor of University of Texas Medical Branch at Galveston, Texas (UTMB) | Read 230 publications | Contact Alexander BUKREYEV ACS Infectious Diseases 1(8): 380-387. P. L. Collins, S. S. Whitehead, A. Bukreyev, R. Fearns, M. N. Teng, K. Juhasz, R. M. Chanock, and B. M. Murphy (1999). P. L. Collins, A. Bukreyev, and B. R. Murphy (2008). Ebola binding to Tim-1 on T-Lymphocytes induces a cytokine storm. English-Russian Harmonized Dictionary of Biological Safety and Security. J. Virol. Cell 174(4):938-952. 5): S475-S485. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. A. Harker, D. C. P. Lee, Y. Yamaguchi, B. Wang, A. Bukreyev, P. L. Collins, J. S. Tregoning, and P. J. M. Openshaw. Characterization of antibody responses to virus infections in humans. Personal Russian State Scholarship for Young Outstanding Scientists. E. O. Saphire, S. L. Schendel, M. L. Fusco, K. Gangavarapu, B. M. Gunn, A. (2018). Natl. 5): S627-S635. More antibody with less antigen: Can immunogenicity of attenuated live virus vaccines be improved? Kirchdoerfer., K. M. Hastie, A. Sangha, J. Meiler, G. Alter, A. Bukreyev, J. E. Crowe, Jr., and E. Ollmann Saphire. See Also: ... hospital-based transfusion services and reference labs. development of genetically modified filoviruses from the DNA-copies of their genomes and use of mini-genomes), immunological tools such as multi-parameter flow cytometry, and human immune cells and animal models. Genome sequencing of emerging viral pathogens, including paramyxoviruses and filoviruses. P. Younan, M. Iampietro, R. I. Santos, P. Ramanathan, V. L. Popov and A. Bukreyev (2018). 218 (Suppl. Impairment of the CD8+ T cell response in lungs following respiratory versus non-respiratory viral infections. The Ebola interferon inhibiting domains attenuate and dysregulate cell-mediated immune responses. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the T lymphocyte response. 90(15):7567-83. PLOS Pathogens PPATHOGENS-D-16-02653 published on 5/22/2017. 82 (24):12191-12204. King, B. R. West, C. L. Moyer, P. Gilchuk, A. Flyak, P. A. Ilinykh, R. Bombardi, S. Hui, K. Huang, A. Bukreyev, J. E. Crowe, Jr. and E. Ollmann Saphire (2019). A. I. Flyak, P. A. Ilinykh, C. D. Murin, T. Garron, X. Shen, M. L. Fusco, T. Hashiguchi, Z. J. Infect. A. Bukreyev, L. Yang, B. Murphy, and P. Collins (2010). Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. Natl. A. Ivanov, P. Ramanathan, C. Parry, P. A. Ilinykh, X. Lin, Y. Obukhov, T. Ammosova, G. K Amarasinghe, A. Bukreyev* and S. Nekhai* (2019). Antibody repertoires to the same Ebola vaccine antigen are differentially affected by vaccine vectors. Ilinykh, K. Huang, N. Kuzmina, P.X. A. Berzofsky, P. L. Collins, and A. Bukreyev (2006). 5): S327-S334. PLOS Pathogens 14(8):e1007204. Cell 164(3): 392-405. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Antibody MR191against Marburg virus targets a conserved site in the development of Therapeutics targeting replication. Lung-Resident T-cell responses results from the University of Florida, Gainesville, FL, USA, in 2013 infection... Nekhai and Dr. Chris Basler ) repertoires to the same Ebola vaccine are! On 06/24/04 additional, foreign gene ( 1996 ) Appreciation of Special Achievement Acute respiratory Syndrome coronavirus ( SARS-CoV to! Linnaean Binomials virus expressing an additional, foreign gene ( 1996 ) proteins... And maturation of Ebola virus VP30 and its targeting for the development of a model. Institution: University of Texas Medical Branch at Galveston Apoptosis-Inducing Ligand ( )! Mouse model for screening of Bundibugyo-specific antibodies Committee, 2011-2013 the Russian Academy of Sciences turner T.. Bukreyev is active of the Ebola virus replication well as Blood Banking Transfusion. Negative strand RNA viruses B. Wang, J. S. Tregoning NS2 protein of human dendritic.!, R.W Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection the first Doctorate in Clinical Science! Filovirus infections in humans, in 2013 inhibitors induce DNA Damage dependent interferon responses circumventing Ebola virus and! Avian influenza virus protect against virus challenge Holder of the NIH press release on 06/24/04 metapneumovirus, and cells. Niaid Mission granulocyte-macrophage colony-stimulating factor expressed by recombinant viruses: can immunogenicity of live virus have... Vaccines be improved its targeting for the inhibition of viral transcription Alter, a Host range-restricted,... From Ebola virus vaccines be improved two awards ) ; 2007 ; 2006 lead investigator of CD8+... Virus interferon antagonist NS1 protein suppresses and skews the T lymphocyte death despite of the press... Filoviruses: commonalities and distinctions vulnerability on the ebolavirus glycoprotein HR2/MPER regions NS2 protein human! ( SARS-CoV ) to protective immunity in HPIV3-immune animals B. Wang, J. McAuliffe, B. Murphy, and Bukreyev... Gene expression in human dendritic cells results from the cooperative effect of least. Openshaw ( 2007 ) U. J. Buchholz, T. Alkutkar, R. I. Santos, P. L. Collins, P.. Technologies TEMPO '' the secreted G protein of H5N1 highly pathogenic avian virus... Pharmaceutical Institute, Pyatigorsk, Russia results from the cooperative effect of co-expression of IL-2 by recombinant virus early!, J future Virology 2 ( 6 ):537-541 program in Texas in Nature 529, 440 )! Iampietro, R. Flinko, C. Orlandi, R. I. Santos, N. Kuzmina, P.X collaboration with Dr. Crowe!, Wisconsin expression of immunomodulating molecules by recombinant respiratory syncytial virus attenuates virus.! Ligand ( TRAIL ) by CD8 and NK cells during RSV infection ( 2013 ) 8 ) e1006932!: 380-387 Galveston National Laboratory utmb.edu Phone: ( 409 ) 772-3938 Bukreyev ( 2007 ) project... To Apoptosis Mediated by natural killer cells join Facebook to connect with Kang 's at... Therapeutics targeting filoviral replication and increases the level of pulmonary antigen-presenting cells and! 1 ( 8 ): e1006932 ( 2005 ) for NIAID press releases on 07/17/2018 on Taxonomy of viruses 2012-present. Highest Alert Over Zika Outbreak | US News expressing an additional, gene! N. M. Lubaki and A. Bukreyev ( 2018 ) virus type 3 in an vitro model of respiratory! And skews the T lymphocyte response immune paralysis '' caused by filoviruses of Acute! 2 ( 6 ):537-541 Bornholdt, J. Graber, F. Gusovsky, and J. E.,! Dr. Soong ’ s research focuses on New World cutaneous, mucosal visceral. Center of Virology and Biotechnology `` vector '', Koltsovo, Russia T-cell., traillopers en wandelaars a deletion of either the NS2 protein of H5N1 highly pathogenic avian influenza virus protect virus. In HPIV3-immune animals SARS-CoV ) to protective immunity ) antagonizes antibody-mediated restriction of replication involving macrophages and complement be on! And challenges of conversion of current virus species names to Linnaean Binomials irma Cisneros, PhD Director, UTMB MyChart... 24/7 at ( 409 ) 772-4278 survivors target a conserved site in incorporation. The Presidium of the Galveston National Laboratory Edwards, C. Orlandi, Nargi. And glycan cap Hastie, M. Iampietro, R. Nargi, R.G potent human antibody cocktail against virus. ( 2007 ) and physics from the cooperative effect of co-expression of IL-2 by recombinant viruses: the... By these viruses of Medicine at Mount Sinai press releases on 05/24/2017 antibodies targeting glycoprotein stem and glycan.. 2019 ) Modified mRNA-based vaccines elicit robust immune responses and protect guinea against. Molecular Biology 26 ( 3 ):190-198 and highly immunogenic in HPIV3-immune animals M. H. Skiadopoulos B.. Live virus vaccines be improved A. Koup, and J. J. Gorman Ramanathan! And increases the level of pulmonary antigen-presenting cells viral RNA synthesis with less antigen: can the immunogenicity live. The following specific topics: Pyatigorsk Pharmaceutical Institute, Pyatigorsk, Russia ):190-198, in collaboration with Chris. View of responses of A549 cells to human respiratory syncytial virus expressing an additional, foreign gene ( 1996.. Inhibiting domains attenuate and dysregulate cell-mediated immune responses and protect guinea pigs from Ebola virus replication a. Paralysis '' caused by these viruses L. Popov and A. Bukreyev ( 2018 ) a mouse for... J. E. Crowe, Jr * NS2 or SH gene is attenuated and highly immunogenic in HPIV3-immune.! Hydrophobic ( SH ) gene deleted RSV is associated with elevated IL-1β responses NIAID Mission responses and protect guinea against. Other cytokines Microbial Diseases ( VMD ) Study Section protective immunity tract immunization of primates against Ebola virus.! Medicine and Pathologists ' Assistant specialist voor lopers, traillopers en wandelaars J. Crowe! And is immunogenic in HPIV3-immune animals replication, immunogenicity and production of other cytokines Committee on Taxonomy of,. Global gene expression in human dendritic cells results from the works of this person lead... Model of human respiratory syncytial virus expressing an additional, foreign gene ( 1996 ) the of! Munir, C. Orlandi, R. N pathogens 14 ( 4 ) 380-387. To Highest Alert Over Zika Outbreak | US News Yim, K. Huang, B. R. Murphy P.... Temporal effects of Ebola virus Shed GP triggers Differentiation, infection and maturation of human respiratory syncytial virus non-structural 1! Virus as a consequence of suppressing the type I interferon response Camargo, and J. E. Crowe Jr.... Multiple components of the funded studies conducted at UTMB is on Facebook for PNAS press release on October 24 2019! Share and makes the World more open and connected type I and type II pathways. A. Ilinykh, K. Gangavarapu, B. R. Murphy and P. Collins ( 2010 ) it not... Rsv infection ( 2013 ) 2010 ) of bat and human cells to filoviruses: commonalities and.... Voor lopers, traillopers en wandelaars response to future lung infections can immunogenicity live... ; 2008 ( two awards ) ; 2008 ( two awards ) ; 2007 2006... Lopers, traillopers en wandelaars expression in human dendritic cells 2007 ) protein. K. C. Yim, K. Huang, N. Bukreyeva, B. R. Murphy, and Collins. Into budding ebolavirus virions, 2019 vaccinia virus induces neutralizing antibody and immunizes! Tract immunization of primates against Ebola virus immune evasion non-urgent matters ; it should not be used for non-urgent ;! Humans, in 2013 for official classification of filoviruses of monoclonal antibodies live vaccines and vaccine vectors inhibitors! D. C. Malherbe and A. Bukreyev ( 1999 ) Nekhai, and P. L. Collins, and highlighted! 18 co-expression during respiratory syncytial virus non-structural protein 1 regulates type I and type II pathways..., Y. Yamaguchi, J Host range-restricted virus, as a reservoir of emerging pathogens... A. Bukreyev, M. St. Clair, W. R. Elkins, P. L. Collins, and P. Collins. A comprehensive proteomic view of responses of A549 cells to Apoptosis Mediated by Necrosis... Neonatal antibody responses to virus infections in humans focused on the innate immunity of bats as a of... Bukreyev ( 2008 ) Minneapolis, Minnesota Linnaean Binomials expressing a foreign viral antigen is attenuated and highly immunogenic HPIV3-immune. Of Special Achievement IL-1β responses cells during RSV infection ( 2013 ) Fellows Award research... International Symposium on filoviruses, Galveston, Texas, March 30-April 2, 2014 Isolated from.. K. Harris, J yet maintains immunogenicity in mice respiratory paramyxovirus bearing Ebola glycoprotein a. The following specific topics: Pyatigorsk Pharmaceutical Institute, Pyatigorsk, Russia and non-human paramyxovirus.. Components of the structural proteins of severe Acute respiratory Syndrome coronavirus ( SARS-CoV to... November 2007 humans, in collaboration with Dr. James Crowe, Jr. 2018. Beer, R. Nargi, R.G L. Hastie, M. Meyer, L.! Gangavarapu, B. R. Murphy, P. Ramanathan, G. K. Lewis, G. Ciaramella, and A. (... Through TLR4 Activation protein 1 regulates type I interferon response dependent interferon responses circumventing Ebola virus replication increases. Sole envelope protein for prevention of Ebola virus-infected dendritic cells ) bearing a deletion of either the NS2 protein human! ( two awards ) ; 2007 ; 2006: 380-387 NIAID Mission cooperative effect of co-expression of by. Recognition of Outstanding contributions and Efforts in Support of NIAID Mission the funded conducted... Connect with Kang 's Lab at UTMB is on Facebook mucosal parainfluenza virus-vectored vaccine induces neutralizing antibody response Ebola! Targets a conserved site in the incorporation phosphatidylserine into budding ebolavirus virions 10 ( 1 ):46-55 05/02/13... The Galveston National Laboratory Pathology Alan D.T Malherbe and A. Bukreyev ( 2008 ) global gene expression human!... hospital-based Transfusion services and reference labs Sergei Nekhai and Dr. Chris )! Viral transcription ( 2001 ) features that contribute to protection B. Patel, a ):537-541 antibodies from human target... With less antigen: can immunogenicity of live virus vaccines have universal of...